Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up

Growth hormone insensitivity syndrome with immune dysregulation

MONDO:0100210

7 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Growth hormone insensitivity with immune dysregulation 1, autosomal recessive (1) Growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant (0)

Broader categories

Disease (618) Hereditary disease (172) Endocrine system disorder (61) Syndromic disease (24) Hereditary endocrine growth disease (23) Human disease (14) Disease of genetic or genomic mechanism (2) Disease by body system or component (0) Disease by etiologic mechanism (0) Growth hormone insensitivity syndrome (0)
Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1
Sort by
  • New hope for rare immune disorders: upadacitinib trial launches

    Disease control Not yet recruiting

    This study tests the drug upadacitinib (Rinvoq) in 30 people with rare genetic disorders that overactivate the JAK-STAT immune pathway. The trial has four phases over 12 months, including an open-label phase to find the best dose and a randomized withdrawal phase to compare the d…

    Phase: PHASE1, PHASE2 • Sponsor: Lisa Satter • Aim: Disease control

    Last updated Jul 04, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space